Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Obesity HELP
Based on 99,992 articles published since 2008
|||| 31 

These are the 99992 published articles about Obesity that originated from Worldwide during 2008-2018.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline 2019 Canadian guideline for physical activity throughout pregnancy. 2018

Mottola, Michelle F / Davenport, Margie H / Ruchat, Stephanie-May / Davies, Gregory A / Poitras, Veronica J / Gray, Casey E / Jaramillo Garcia, Alejandra / Barrowman, Nick / Adamo, Kristi B / Duggan, Mary / Barakat, Ruben / Chilibeck, Phil / Fleming, Karen / Forte, Milena / Korolnek, Jillian / Nagpal, Taniya / Slater, Linda G / Stirling, Deanna / Zehr, Lori. ·R Samuel McLaughlin Foundation-Exercise and Pregnancy Laboratory, School of Kinesiology, Faculty of Health Sciences, Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Children's Health Research Institute, The University of Western Ontario, London, Ontario, Canada. · Program for Pregnancy and Postpartum Health, Faculty of Kinesiology, Sport and Recreation, Women and Children's Health Research Institute, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Human Kinetics, Universite du Quebec a Trois-Rivieres, Trois-Rivieres, Quebec, Canada. · Department of Obstetrics and Gynecology, Queen's University, Kingston, Ontario, Canada. · Independent Researcher, Ottawa, Ontario, Canada. · Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada. · Clinical Research Unit, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada. · School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada. · Canadian Society for Exercise Physiology, Ottawa, Ontario, Canada. · Facultad de Ciencias de la Actividad Física y del Deporte-INEF, Universidad Politécnica de Madrid, Madrid, Spain. · College of Kinesiology, University of Saskatchewan, Saskatoon, Canada. · Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Family and Community Medicine, University of Toronto, Granovsky Gluskin Family Medicine Centre, Sinai Health System, Sinai Health System, Toronto, Ontario, Canada. · Canadian Association of Midwives, Toronto, Canada. · John W Scott Health Sciences Library, University of Alberta, Edmonton, Alberta, Canada. · Middlesex-London Health Unit, London, Ontario, Canada. · School of Health and Human Services, Camosun College, Victoria, Canada. ·Br J Sports Med · Pubmed #30337460.

ABSTRACT: The objective is to provide guidance for pregnant women and obstetric care and exercise professionals on prenatal physical activity. The outcomes evaluated were maternal, fetal or neonatal morbidity, or fetal mortality during and following pregnancy. Literature was retrieved through searches of MEDLINE, EMBASE, PsycINFO, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Scopus and Web of Science Core Collection, CINAHL Plus with Full Text, Child Development & Adolescent Studies, Education Resources Information Center, SPORTDiscus, ClinicalTrials.gov and the Trip Database from inception up to 6 January 2017. Primary studies of any design were eligible, except case studies. Results were limited to English-language, Spanish-language or French-language materials. Articles related to maternal physical activity during pregnancy reporting on maternal, fetal or neonatal morbidity, or fetal mortality were eligible for inclusion. The quality of evidence was rated using the Grading of Recommendations Assessment, Development and Evaluation methodology. The Guidelines Consensus Panel solicited feedback from end users (obstetric care providers, exercise professionals, researchers, policy organisations, and pregnant and postpartum women). The development of these guidelines followed the Appraisal of Guidelines for Research and Evaluation II instrument. The benefits of prenatal physical activity are moderate and no harms were identified; therefore, the difference between desirable and undesirable consequences (net benefit) is expected to be moderate. The majority of stakeholders and end users indicated that following these recommendations would be feasible, acceptable and equitable. Following these recommendations is likely to require minimal resources from both individual and health systems perspectives.

2 Guideline Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement. 2018

Anonymous3041309 / Curry, Susan J / Krist, Alex H / Owens, Douglas K / Barry, Michael J / Caughey, Aaron B / Davidson, Karina W / Doubeni, Chyke A / Epling, John W / Grossman, David C / Kemper, Alex R / Kubik, Martha / Landefeld, C Seth / Mangione, Carol M / Phipps, Maureen G / Silverstein, Michael / Simon, Melissa A / Tseng, Chien-Wen / Wong, John B. ·University of Iowa, Iowa City. · Fairfax Family Practice Residency, Fairfax, Virginia. · Virginia Commonwealth University, Richmond. · Veterans Affairs Palo Alto Health Care System, Palo Alto, California. · Stanford University, Stanford, California. · Harvard Medical School, Boston, Massachusetts. · Oregon Health & Science University, Portland. · Columbia University, New York, New York. · University of Pennsylvania, Philadelphia. · Virginia Tech Carilion School of Medicine, Roanoke. · Kaiser Permanente Washington Health Research Institute, Seattle. · Nationwide Children's Hospital, Columbus, Ohio. · Temple University, Philadelphia, Pennsylvania. · University of Alabama at Birmingham. · University of California, Los Angeles. · Brown University, Providence, Rhode Island. · Boston University, Boston, Massachusetts. · Northwestern University, Evanston, Illinois. · University of Hawaii, Honolulu. · Pacific Health Research and Education Institute, Honolulu, Hawaii. · Tufts University, Medford, Massachusetts. ·JAMA · Pubmed #30326502.

ABSTRACT: Importance: More than 35% of men and 40% of women in the United States are obese. Obesity is associated with health problems such as increased risk for coronary heart disease, type 2 diabetes, various types of cancer, gallstones, and disability. Obesity is also associated with an increased risk for death, particularly among adults younger than 65 years. Objective: To update the US Preventive Services Task Force (USPSTF) 2012 recommendation on screening for obesity in adults. Evidence Review: The USPSTF reviewed the evidence on interventions (behavioral and pharmacotherapy) for weight loss or weight loss maintenance that can be provided in or referred from a primary care setting. Surgical weight loss interventions and nonsurgical weight loss devices (eg, gastric balloons) are considered to be outside the scope of the primary care setting. Findings: The USPSTF found adequate evidence that intensive, multicomponent behavioral interventions in adults with obesity can lead to clinically significant improvements in weight status and reduce the incidence of type 2 diabetes among adults with obesity and elevated plasma glucose levels; these interventions are of moderate benefit. The USPSTF found adequate evidence that behavior-based weight loss maintenance interventions are of moderate benefit. The USPSTF found adequate evidence that the harms of intensive, multicomponent behavioral interventions (including weight loss maintenance interventions) in adults with obesity are small to none. Therefore, the USPSTF concludes with moderate certainty that offering or referring adults with obesity to intensive behavioral interventions or behavior-based weight loss maintenance interventions has a moderate net benefit. Conclusions and Recommendation: The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral interventions. (B recommendation).

3 Guideline The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. 2018

Chalasani, Naga / Younossi, Zobair / Lavine, Joel E / Charlton, Michael / Cusi, Kenneth / Rinella, Mary / Harrison, Stephen A / Brunt, Elizabeth M / Sanyal, Arun J. ·Indiana University School of Medicine, Indianapolis, IN. · Center for Liver Disease and Department of Medicine, Inova Fairfax Hospital, Falls Church, VA. · Columbia University, New York, NY. · University of Chicago, Chicago, IL. · University of Florida, Gainesville, FL. · Northwestern University, Chicago, IL. · Pinnacle Clinical Research, San Antonio, TX. · Washington University School of Medicine, St. Louis, MO. · Virginia Commonwealth University, Richmond, VA. ·Hepatology · Pubmed #28714183.

ABSTRACT: -- No abstract --

4 Guideline [Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. 2017

Simon, Nicolas / Coiteux, Valérie / Bruno, Bénédicte / Taque, Sophie / Charbonnier, Amandine / Souchet, Laetitia / Vincent, Laure / Yakoub-Agha, Ibrahim / Chalandon, Yves. ·Université de Lille, EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France; CHU de Lille, institut de pharmacie, 59000 Lille, France. · CHU de Lille, service des maladies du sang, 59000 Lille, France. · CHU de Lille, service d'hématologie pédiatrique, 59000 Lille, France. · CHU Anne de Bretagne, service d'hémato-oncologie pédiatrique, 2, rue Henri-Le- Guilloux, 35033 Rennes cedex 9, France. · CHU, service d'hématologie clinique et de thérapie cellulaire, 80054 Amiens cedex 1, France. · Groupe hospitalier Pitié-Salpêtrière, service d'hématologie clinique, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · CHU, département d'hématologie clinique, 191, avenue du Doyen-Gaston-Giraud, 34295 Montpellier, France. · CHU de Lille, LIRIC Inserm U995, université de Lille 2, 59000 Lille, France. Electronic address: Ibrahim.YAKOUBAGHA@CHRU-LILLE.FR. · Hôpitaux universitaires de Genève et faculté de médecine université de Genève, service d'hématologie, 4, rue Gabrielle-Perret-Gentil, 1205 Genève, Suisse. ·Bull Cancer · Pubmed #29173979.

ABSTRACT: In September 2016 in Lille, France, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 7th Allogeneic Stem Cell Transplantation Clinical Practices Harmonization Workshop Series. Our work group focused on chemotherapy drug dose adaptation for hematopoietic stem cell transplantation patients presenting a comorbidity. The purpose of this workshop was to provide recommendations on chemotherapy drug dose adaptation for patient populations receiving hematopoietic stem cell transplantation who also had the following comorbidities: obesity, chronic kidney disease and hepatopathy.

5 Guideline Committee Opinion No. 714: Obesity in Adolescents. 2017

Anonymous641200. · ·Obstet Gynecol · Pubmed #28832485.

ABSTRACT: Rates of obesity among adolescents in the United States have increased at a dramatic rate along with the prevalence of weight-related diseases. Between the 1980s and 2014, the prevalence of obesity among adolescent females in the United States increased from approximately 10% to 21%. Although the steep increase in the prevalence of obesity in children (2-11 years) has slowed, the prevalence of obesity in adolescents (12-19 years) continues to increase. Because the obese female adolescent faces medical, psychologic, and reproductive health challenges, early intervention is imperative in preventing short-term and long-term morbidity. The obstetrician-gynecologist who is knowledgeable about the behavioral and environmental factors that influence obesity may be better able to educate parents, guardians, and adolescents and advocate for programs that increase physical activity and improve nutrition. The obstetrician-gynecologist should be able to identify obese adolescents, particularly those at risk of comorbid conditions. They may have the opportunity to initiate behavioral counseling, participate in multidisciplinary teams that care for overweight and obese adolescents, and advocate for community programs to prevent obesity.

6 Guideline Committee Opinion No. 714 Summary: Obesity in Adolescents. 2017

Anonymous561200. · ·Obstet Gynecol · Pubmed #28832476.

ABSTRACT: Rates of obesity among adolescents in the United States have increased at a dramatic rate along with the prevalence of weight-related diseases. Between the 1980s and 2014, the prevalence of obesity among adolescent females in the United States increased from approximately 10% to 21%. Although the steep increase in the prevalence of obesity in children (2-11 years) has slowed, the prevalence of obesity in adolescents (12-19 years) continues to increase. Because the obese female adolescent faces medical, psychologic, and reproductive health challenges, early intervention is imperative in preventing short-term and long-term morbidity. The obstetrician-gynecologist who is knowledgeable about the behavioral and environmental factors that influence obesity may be better able to educate parents, guardians, and adolescents and advocate for programs that increase physical activity and improve nutrition. The obstetrician-gynecologist should be able to identify obese adolescents, particularly those at risk of comorbid conditions. They may have the opportunity to initiate behavioral counseling, participate in multidisciplinary teams that care for overweight and obese adolescents, and advocate for community programs to prevent obesity.

7 Guideline Indian College of Physicians Position Statement on Anemia in Metabolic Syndrome. 2017

Sahay, Manisha / Kalra, Sanjay / Tiwaskar, Mangesh / Ghosh, Sujoy / Badani, Rajesh / Bantwal, Ganapathi / Das, A K / Dhorepatil, Bharti / Jeloka, Tarun / Khandelwal, Deepak / Nadkar, Milind Y / Saboo, Banshi / Sahay, Rakesh / Unnikrishnan, A G / Aggarwal, Sameer / Agrawal, Navneet / Bajaj, Sarita / Baruah, Manash P / Chadha, Manoj / Das, Sambit / Dhamija, Puneet / Julka, Sandeep / Mehta, Prashant / Shah, Siddharth N / Sharma, Balram / Muruganathan, A. ·Osmania Medical college, Hyderabad, Telangana. · Bharti Hospital, Karnal, Haryana. · Asian Heart Institute and Research Centre, Mumbai, Maharashtra. · IGPGMER, Kolkata, West Bengal. · Aditya Birla Memorial Hospital, Pune, Maharashtra. · St Johns Medical College and Hospital, Bengaluru, Karnataka. · Pondicherry Institute of Medical Sciences, Puducherry. · Shree Hospital, Pune, Maharashtra. · Maharaja Agrasen Hospital, Punjabi Bagh, Delhi. · Seth G.S. Medical College and KEM Hospital, Mumbai, Maharashtra. · Dia Care - Diabetes Care and Hormone Clinic, Ambawadi, Ahmedabad, Gujarat. · Chellaram Diabetes Institute, Pune, Maharashtra. · Post Graduate Institute of Medical Sciences, Rohtak, Haryana. · Diabetes Obesity and Thyroid Centre, Gwalior, Madhya Pradesh. · MLN Medical College, Allahabad, India. · Excel Centre Hospitals, Guwahati, Assam. · Hinduja Hospital, Mumbai, Maharashtra. · Apollo Hospitals, Bhubaneshwar, Orissa. · AIIMS, Rishikesh, Uttarakhand. · Radiance - The Hormone Health Clinic, Indore, Madhya Pradesh. · Asian Hospital, Faridabad, Haryana. · Bhatia Hospital, Tardeo. · SMS Medical College and Hospital, Jaipur, Rajasthan. · Coimbatore, Tamil Nadu. ·J Assoc Physicians India · Pubmed #28782315.

ABSTRACT: -- No abstract --

8 Guideline [2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]. 2017

Piepoli, Massimo F / Hoes, Arno W / Agewall, Stefan / Albus, Christian / Brotons, Carlos / Catapano, Alberico L / Cooney, Marie-Therese / Corrà, Ugo / Cosyns, Bernard / Deaton, Christi / Graham, Ian / Hall, Michael Stephen / Hobbs, F D Richard / Løchen, Maja-Lisa / Löllgen, Herbert / Marques-Vidal, Pedro / Perk, Joep / Prescott, Eva / Redon, Josep / Richter, Dimitrios J / Sattar, Naveed / Smulders, Yvo / Tiberi, Monica / van der Worp, H Bart / van Dis, Ineke / Verschuren, W M Monique. ·European Society of Cardiology (ESC). · International Society of Behavioural Medicine (ISBM). · WONCA Europe. · European Atherosclerosis Society (EAS). · International Diabetes Federation European Region (IDF Europe). · International Federation of Sport Medicine (FIMS). · European Society of Hypertension (ESH). · European Association for the Study of Diabetes (EASD). · European Stroke Organisation (ESO). · European Heart Network (EHN). ·G Ital Cardiol (Rome) · Pubmed #28714997.

ABSTRACT: -- No abstract --

9 Guideline Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. 2017

de Raaff, Christel A L / Gorter-Stam, Marguerite A W / de Vries, Nico / Sinha, Ashish C / Jaap Bonjer, H / Chung, Frances / Coblijn, Usha K / Dahan, Albert / van den Helder, Rick S / Hilgevoord, Antonius A J / Hillman, David R / Margarson, Michael P / Mattar, Samer G / Mulier, Jan P / Ravesloot, Madeline J L / Reiber, Beata M M / van Rijswijk, Anne-Sophie / Singh, Preet Mohinder / Steenhuis, Roos / Tenhagen, Mark / Vanderveken, Olivier M / Verbraecken, Johan / White, David P / van der Wielen, Nicole / van Wagensveld, Bart A. ·Department of Surgery, OLVG West, Amsterdam, the Netherlands. Electronic address: c.deraaff@olvg.nl. · Department of Surgery, VU Medical Center, Amsterdam, the Netherlands. · Department of Oral Kinesiology, ACTA, Amsterdam, the Netherlands; Department of Otorhinolaryngology and Head and Neck Surgery, Translational Neurosciences Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Department of Otorhinolaryngology, OLVG West, Amsterdam, the Netherlands. · Department of Anesthesiology and Perioperative Medicine, Temple University, Philadelphia, PA, USA. · Department of Anesthesiology, University Health Network, University of Toronto, Toronto, Canada. · Department of Anesthesiology, LUMC, Leiden, the Netherlands. · Department of Surgery, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands. · Department of Clinical Neurophysiology, OLVG West, Amsterdam, the Netherlands. · Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Anaesthesia, Saint Richard's Hospital, Chichester, United Kingdom. · Department of Surgery, Oregon Health & Science University, Portland, Oregon, USA. · Department of Anesthesiology, AZ Sint Jan, Brugge, Belgium. · Department of Otorhinolaryngology, OLVG West, Amsterdam, the Netherlands. · Department of Surgery, Rode Kruis Ziekenhuis, Beverwijk, the Netherlands. · Department of Surgery, MC Slotervaart, Amsterdam, the Netherlands. · Department of Anesthesiology, All India Institute of Medical Sciences, New Delhi, India. · Medical Library, OLVG West, Amsterdam, the Netherlands. · Department of Otorhinolaryngology and Head and Neck Surgery, Translational Neurosciences Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Department of Pulmonary Medicine and Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Edegem, Belgium. · Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Surgery, OLVG West, Amsterdam, the Netherlands. ·Surg Obes Relat Dis · Pubmed #28666588.

ABSTRACT: BACKGROUND: The frequency of metabolic and bariatric surgery (MBS) is increasing worldwide, with over 500,000 cases performed every year. Obstructive sleep apnea (OSA) is present in 35%-94% of MBS patients. Nevertheless, consensus regarding the perioperative management of OSA in MBS patients is not established. OBJECTIVES: To provide consensus based guidelines utilizing current literature and, when in the absence of supporting clinical data, expert opinion by organizing a consensus meeting of experts from relevant specialties. SETTING: The meeting was held in Amsterdam, the Netherlands. METHODS: A panel of 15 international experts identified 75 questions covering preoperative screening, treatment, postoperative monitoring, anesthetic care and follow-up. Six researchers reviewed the literature systematically. During this meeting, the "Amsterdam Delphi Method" was utilized including controlled acquisition of feedback, aggregation of responses and iteration. RESULTS: Recommendations or statements were provided for 58 questions. In the judgment of the experts, 17 questions provided no additional useful information and it was agreed to exclude them. With the exception of 3 recommendations (64%, 66%, and 66% respectively), consensus (>70%) was reached for 55 statements and recommendations. Several highlights: polysomnography is the gold standard for diagnosing OSA; continuous positive airway pressure is recommended for all patients with moderate and severe OSA; OSA patients should be continuously monitored with pulse oximetry in the early postoperative period; perioperative usage of sedatives and opioids should be minimized. CONCLUSION: This first international expert meeting provided 58 statements and recommendations for a clinical consensus guideline regarding the perioperative management of OSA patients undergoing MBS.

10 Guideline White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. 2017

Acosta, Andres / Streett, Sarah / Kroh, Mathew D / Cheskin, Lawrence J / Saunders, Katherine H / Kurian, Marina / Schofield, Marsha / Barlow, Sarah E / Aronne, Louis. ·Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: acostacardenas.andres@mayo.edu. · Inflammatory Bowel Disease, Stanford University School of Medicine, Stanford, California. · Department of Surgical Endoscopy, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. · Johns Hopkins Weight Management Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. · Comprehensive Weight Control Center, Weill Cornell Medical College, New York, New York and representative of The Obesity Society. · Department of Minimally Invasive Surgery, New York University, New York, New York. · Nutrition Services Coverage, Academy of Nutrition and Dietetics, Chicago, Illinois. · Baylor College of Medicine and Center for Childhood Obesity, Texas Children's Hospital, Houston, Texas and representative of North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. ·Clin Gastroenterol Hepatol · Pubmed #28242319.

ABSTRACT: The epidemic of obesity continues at alarming rates, with a high burden to our economy and society. The American Gastroenterological Association understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidisciplinary approach to the management of obesity. Because gastrointestinal disorders resulting from obesity are more frequent and often present sooner than type 2 diabetes mellitus and cardiovascular disease, gastroenterologists have an opportunity to address obesity and provide an effective therapy early. Patients who are overweight or obese already fill gastroenterology clinics with gastroesophageal reflux disease and its associated risks of Barrett's esophagus and esophageal cancer, gallstone disease, nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, and colon cancer. Obesity is a major modifiable cause of diseases of the digestive tract that frequently goes unaddressed. As internists, specialists in digestive disorders, and endoscopists, gastroenterologists are in a unique position to play an important role in the multidisciplinary treatment of obesity. This American Gastroenterological Association paper was developed with content contribution from Society of American Gastrointestinal and Endoscopic Surgeons, The Obesity Society, Academy of Nutrition and Dietetics, and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, endorsed with input by American Society for Gastrointestinal Endoscopy, American Society for Metabolic and Bariatric Surgery, American Association for the Study of Liver Diseases, and Obesity Medicine Association, and describes POWER: Practice Guide on Obesity and Weight Management, Education and Resources. Its objective is to provide physicians with a comprehensive, multidisciplinary process to guide and personalize innovative obesity care for safe and effective weight management.

11 Guideline Combined hormonal contraception and the risk of venous thromboembolism: a guideline. 2017

Anonymous420953 / Anonymous430953. ·American Society for Reproductive Medicine, Birmingham, Alabama. ·Fertil Steril · Pubmed #27793376.

ABSTRACT: While venous thromboembolism (VTE) is rare in young women of reproductive age, combined oral contraceptives increase the risk of VTE. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.

12 Guideline ESPEN guidelines on definitions and terminology of clinical nutrition. 2017

Cederholm, T / Barazzoni, R / Austin, P / Ballmer, P / Biolo, G / Bischoff, S C / Compher, C / Correia, I / Higashiguchi, T / Holst, M / Jensen, G L / Malone, A / Muscaritoli, M / Nyulasi, I / Pirlich, M / Rothenberg, E / Schindler, K / Schneider, S M / de van der Schueren, M A E / Sieber, C / Valentini, L / Yu, J C / Van Gossum, A / Singer, P. ·Departments of Geriatric Medicine, Uppsala University Hospital and Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden. Electronic address: tommy.cederholm@pubcare.uu.se. · Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. Electronic address: barazzon@units.it. · Pharmacy Department, Oxford University Hospitals NHS Foundation Trust, United Kingdom; Pharmacy Department, University Hospital Southampton NHS Foundation Trust, United Kingdom. Electronic address: peter.austin@uhs.nhs.uk. · Department of Medicine, Kantonsspital Winterthur, Winterthur, Switzerland. Electronic address: peter.ballmer@ksw.ch. · Institute of Clinical Medicine, University of Trieste, Trieste, Italy. Electronic address: biolo@units.it. · Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany. Electronic address: bischoff.stephan@uni-hohenheim.de. · School of Nursing, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: compherc@nursing.upenn.edu. · Department of Surgery, Federal University of Minas Gerais, Belo Horizonte, Brazil. Electronic address: isabel_correia@uol.com.br. · Department of Surgery and Palliative Medicine, Fujita Health University, School of Medicine, Toyoake, Japan. Electronic address: t-gucci30219@herb.ocn.ne.jp. · Center for Nutrition and Bowel Disease, Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark. Electronic address: mette.holst@rn.dk. · The Dean's Office and Department of Medicine, The University of Vermont College of Medicine, Burlington, VT, USA. Electronic address: gordon.jensen@med.uvm.edu. · Pharmacy Department, Mount Carmel West Hospital, Columbus, OH, USA. Electronic address: ainsleym@nutritioncare.org. · Department of Clinical Medicine, Sapienza University of Rome, Italy. Electronic address: maurizio.muscaritoli@uniroma1.it. · Nutrition and Dietetics, Alfred Health, Melbourne, Australia. Electronic address: i.nyulasi@alfred.org.au. · Department of Internal Medicine, Elisabeth Protestant Hospital, Berlin, Germany. Electronic address: matthias.pirlich@pgdiakonie.de. · Department of Food and Meal Science, Kristianstad University, Kristianstad, Sweden. Electronic address: elisabet.rothenberg@vgregion.se. · Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University Vienna, Vienna, Austria. Electronic address: karin.schindler@meduniwien.ac.at. · Department of Gastroenterology and Clinical Nutrition, Archet Hospital, University of Nice Sophia Antipolis, Nice, France. Electronic address: stephane.schneider@unice.fr. · Department of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands; Department of Nutrition, Sports and Health, Faculty of Health and Social Studies, HAN University of Applied Sciences, Nijmegen, The Netherlands. Electronic address: m.devanderschueren@vumc.nl. · Institute for Biomedicine of Ageing, Friedrich-Alexander University Erlangen-Nürnberg, Hospital St. John of Lord, Regensburg, Germany. Electronic address: cornel.sieber@fau.de. · Department of Agriculture and Food Sciences, Section of Dietetics, University of Applied Sciences, Neubrandenburg, Germany. Electronic address: valentini@hs-nb.de. · Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: yu-jch@163.com. · Department of Gastroenterology, Clinic of Intestinal Diseases and Nutritional Support, Hopital Erasme, Free University of Brussels, Brussels, Belgium. Electronic address: Andre.VanGossum@erasme.ulb.ac.be. · Department of Critical Care, Institute for Nutrition Research, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tikva 49100 Israel. Electronic address: pierre.singer@gmail.com. ·Clin Nutr · Pubmed #27642056.

ABSTRACT: BACKGROUND: A lack of agreement on definitions and terminology used for nutrition-related concepts and procedures limits the development of clinical nutrition practice and research. OBJECTIVE: This initiative aimed to reach a consensus for terminology for core nutritional concepts and procedures. METHODS: The European Society of Clinical Nutrition and Metabolism (ESPEN) appointed a consensus group of clinical scientists to perform a modified Delphi process that encompassed e-mail communication, face-to-face meetings, in-group ballots and an electronic ESPEN membership Delphi round. RESULTS: Five key areas related to clinical nutrition were identified: concepts; procedures; organisation; delivery; and products. One core concept of clinical nutrition is malnutrition/undernutrition, which includes disease-related malnutrition (DRM) with (eq. cachexia) and without inflammation, and malnutrition/undernutrition without disease, e.g. hunger-related malnutrition. Over-nutrition (overweight and obesity) is another core concept. Sarcopenia and frailty were agreed to be separate conditions often associated with malnutrition. Examples of nutritional procedures identified include screening for subjects at nutritional risk followed by a complete nutritional assessment. Hospital and care facility catering are the basic organizational forms for providing nutrition. Oral nutritional supplementation is the preferred way of nutrition therapy but if inadequate then other forms of medical nutrition therapy, i.e. enteral tube feeding and parenteral (intravenous) nutrition, becomes the major way of nutrient delivery. CONCLUSION: An agreement of basic nutritional terminology to be used in clinical practice, research, and the ESPEN guideline developments has been established. This terminology consensus may help to support future global consensus efforts and updates of classification systems such as the International Classification of Disease (ICD). The continuous growth of knowledge in all areas addressed in this statement will provide the foundation for future revisions.

13 Guideline The rehabilitation of children and adolescents with severe or medically complicated obesity: an ISPED expert opinion document. 2017

Grugni, Graziano / Licenziati, Maria Rosaria / Valerio, Giuliana / Crinò, Antonino / Maffeis, Claudio / Tanas, Rita / Morino, Giuseppe Stefano / Anonymous3850880. ·Division of Auxology, Italian Auxological Institute, Verbania, Italy. · Department of Pediatrics, AORN Santobono-Pausilipon, Naples, Italy. mrlicenziati@gmail.com. · Department of Movement Sciences and Wellness, Parthenope University, Naples, Italy. · Autoimmune Endocrine Diseases Unit Bambino Gesù Hospital, Research Hospital Palidoro, Rome, Italy. · Pediatric Diabetes and Metabolic Disorders Unit, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy. · Pediatric Unit, Azienda Ospedaliera Universitaria, Ferrara, Italy. · Nutrition Education Unit, Bambino Gesù Hospital, San Paolo Hospital, Rome, Italy. ·Eat Weight Disord · Pubmed #27585923.

ABSTRACT: Severe/medically complicated obesity in childhood, and particularly in adolescence, is a real disability that requires an intensive and continuous approach which should follow the procedures and schedule of rehabilitation medicine. Given the lack of a specific document focusing on children and adolescents, the Childhood Obesity Study Group set out to explore the available evidence for the treatment of severe or medically complicated obesity and to set standards tailored to the specific context of the Italian Health Service. Through a series of meetings and electronic communications, the writing committee (selected from members of the Study Group) selected the key issues, explored the literature and produced a draft document which was submitted to the other experts until the final synthesis was approved by the group. In brief, the following issues were involved: (1) definition and epidemiology; (2) identification of common goals designed to regain functional competence and limit the progression of metabolic and psychological complications; (3) a multi-professional team approach; (4) the care setting. This paper is an expert opinion document on the rehabilitation of severe and medically complicated obesity in children and adolescents produced by experts belonging to the Childhood Obesity Study Group of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).

14 Guideline Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology. 2017

Bellizzi, Vincenzo / Conte, Giuseppe / Borrelli, Silvio / Cupisti, Adamasco / De Nicola, Luca / Di Iorio, Biagio R / Cabiddu, Gianfranca / Mandreoli, Marcora / Paoletti, Ernesto / Piccoli, Giorgina B / Quintaliani, Giuseppe / Ravera, Maura / Santoro, Domenico / Torraca, Serena / Minutolo, Roberto / Anonymous6920879. ·Division of Nephrology, Dialysis and Transplantation, Nephrology Unit, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Via San Leonardo, 84131, Salerno, Italy. vincenzo.bellizzi@tin.it. · Nephrology Division, Second University of Naples, Naples, Italy. · Dept. of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Nephrology Unit, Landolfi Hospital, Solofra, AV, Italy. · Nephrology Division, Brotzu Hospital, Cagliari, Italy. · Nephrology and Dialysis Unit, Ospedale S. Maria della Scaletta, Imola, BO, Italy. · Nephrology Unit, University of Genoa and IRCCS A.O.U. San Martino IST, Genoa, Italy. · Dept. of Clinical and Biological Sciences, University of Torino, Torino, Italy. · Nephrologie, CH Le Mans, Le Mans, France. · O. U. Nephrology, Dialysis and Transplantation, Santa Maria della Misericordia Hospital, Perugia, Italy. · Dept. of Internal Medicine, University of Messina, Messina, Italy. · Division of Nephrology, Dialysis and Transplantation, Nephrology Unit, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Via San Leonardo, 84131, Salerno, Italy. ·J Nephrol · Pubmed #27568307.

ABSTRACT: This position paper of the study group "Conservative treatment of Chronic Kidney Disease-CKD" of the Italian Society of Nephrology addresses major practical, unresolved, issues related to the conservative treatment of chronic renal disease. Specifically, controversial topics from everyday clinical nephrology practice which cannot find a clear, definitive answer in the current literature or in nephrology guidelines are discussed. The paper reports the point of view of the study group. Concise and practical advice is given on several common issues: renal biopsy in diabetes; dual blockade of the renin-angiotensin-aldosterone system (RAAS); management of iron deficiency; low protein diet; dietary salt intake; bicarbonate supplementation; treatment of obesity; the choice of conservative therapy vs. dialysis. For each topic synthetic statements, guideline-style, are reported.

15 Guideline Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. 2016

Bozkurt, Biykem / Aguilar, David / Deswal, Anita / Dunbar, Sandra B / Francis, Gary S / Horwich, Tamara / Jessup, Mariell / Kosiborod, Mikhail / Pritchett, Allison M / Ramasubbu, Kumudha / Rosendorff, Clive / Yancy, Clyde / Anonymous481246. · ·Circulation · Pubmed #27799274.

ABSTRACT: -- No abstract --

16 Guideline Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. 2016

Murray, Michael J / DeBlock, Heidi / Erstad, Brian / Gray, Anthony / Jacobi, Judi / Jordan, Che / McGee, William / McManus, Claire / Meade, Maureen / Nix, Sean / Patterson, Andrew / Sands, M Karen / Pino, Richard / Tescher, Ann / Arbour, Richard / Rochwerg, Bram / Murray, Catherine Friederich / Mehta, Sangeeta. ·1Geisinger Medical Center, Danville, PA. 2Albany Medical Center, Albany, NY. 3University of Arizona College of Pharmacy, Tucson, AZ. 4Clinic Medical Center, Burlington, MA. 5Indiana University, Indiana, IN. 6Grand Strand Medical Center, Myrtle Beach, SC. 7Baystate Medical Center, Springfield, MA. 8Saint Elizabeth's Medical Center, Boston, MA. 9University of Toronto, Toronto, Canada. 10Riverside Medical Group, Yorktown, VA. 11University of Nebraska Medical Center, Omaha, NE. 12Novant Health, Clemmons, NC. 13Massachusetts General Hospital, Boston, MA. 14Mayo Clinic, Rochester, MN. 15Lancaster General Hospital, Lancaster, PA. 16McMaster University, Hamilton, Ontario, Canada. 17Medscape, New York, NY. 18University of Toronto, Toronto, Canada. ·Crit Care Med · Pubmed #27755068.

ABSTRACT: OBJECTIVE: To update the 2002 version of "Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient." DESIGN: A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of neuromuscular-blocking agents; a Grading of Recommendations Assessment, Development, and Evaluation expert; and a medical writer met via teleconference and three face-to-face meetings and communicated via e-mail to examine the evidence and develop these practice guidelines. Annually, all members completed conflict of interest statements; no conflicts were identified. This activity was funded by the Society for Critical Care Medicine, and no industry support was provided. METHODS: Using the Grading of Recommendations Assessment, Development, and Evaluation system, the Grading of Recommendations Assessment, Development, and Evaluation expert on the Task Force created profiles for the evidence related to six of the 21 questions and assigned quality-of-evidence scores to these and the additional 15 questions for which insufficient evidence was available to create a profile. Task Force members reviewed this material and all available evidence and provided recommendations, suggestions, or good practice statements for these 21 questions. RESULTS: The Task Force developed a single strong recommendation: we recommend scheduled eye care that includes lubricating drops or gel and eyelid closure for patients receiving continuous infusions of neuromuscular-blocking agents. The Task Force developed 10 weak recommendations. 1) We suggest that a neuromuscular-blocking agent be administered by continuous intravenous infusion early in the course of acute respiratory distress syndrome for patients with a PaO2/FIO2 less than 150. 2) We suggest against the routine administration of an neuromuscular-blocking agents to mechanically ventilated patients with status asthmaticus. 3) We suggest a trial of a neuromuscular-blocking agents in life-threatening situations associated with profound hypoxemia, respiratory acidosis, or hemodynamic compromise. 4) We suggest that neuromuscular-blocking agents may be used to manage overt shivering in therapeutic hypothermia. 5) We suggest that peripheral nerve stimulation with train-of-four monitoring may be a useful tool for monitoring the depth of neuromuscular blockade but only if it is incorporated into a more inclusive assessment of the patient that includes clinical assessment. 6) We suggest against the use of peripheral nerve stimulation with train of four alone for monitoring the depth of neuromuscular blockade in patients receiving continuous infusion of neuromuscular-blocking agents. 7) We suggest that patients receiving a continuous infusion of neuromuscular-blocking agent receive a structured physiotherapy regimen. 8) We suggest that clinicians target a blood glucose level of less than 180 mg/dL in patients receiving neuromuscular-blocking agents. 9) We suggest that clinicians not use actual body weight and instead use a consistent weight (ideal body weight or adjusted body weight) when calculating neuromuscular-blocking agents doses for obese patients. 10) We suggest that neuromuscular-blocking agents be discontinued at the end of life or when life support is withdrawn. In situations in which evidence was lacking or insufficient and the study results were equivocal or optimal clinical practice varies, the Task Force made no recommendations for nine of the topics. 1) We make no recommendation as to whether neuromuscular blockade is beneficial or harmful when used in patients with acute brain injury and raised intracranial pressure. 2) We make no recommendation on the routine use of neuromuscular-blocking agents for patients undergoing therapeutic hypothermia following cardiac arrest. 3) We make no recommendation on the use of peripheral nerve stimulation to monitor degree of block in patients undergoing therapeutic hypothermia. 4) We make no recommendation on the use of neuromuscular blockade to improve the accuracy of intravascular-volume assessment in mechanically ventilated patients. 5) We make no recommendation concerning the use of electroencephalogram-derived parameters as a measure of sedation during continuous administration of neuromuscular-blocking agents. 6) We make no recommendation regarding nutritional requirements specific to patients receiving infusions of neuromuscular-blocking agents. 7) We make no recommendation concerning the use of one measure of consistent weight over another when calculating neuromuscular-blocking agent doses in obese patients. 8) We make no recommendation on the use of neuromuscular-blocking agents in pregnant patients. 9) We make no recommendation on which muscle group should be monitored in patients with myasthenia gravis receiving neuromuscular-blocking agents. Finally, in situations in which evidence was lacking or insufficient but expert consensus was unanimous, the Task Force developed six good practice statements. 1) If peripheral nerve stimulation is used, optimal clinical practice suggests that it should be done in conjunction with assessment of other clinical findings (e.g., triggering of the ventilator and degree of shivering) to assess the degree of neuromuscular blockade in patients undergoing therapeutic hypothermia. 2) Optimal clinical practice suggests that a protocol should include guidance on neuromuscular-blocking agent administration in patients undergoing therapeutic hypothermia. 3) Optimal clinical practice suggests that analgesic and sedative drugs should be used prior to and during neuromuscular blockade, with the goal of achieving deep sedation. 4) Optimal clinical practice suggests that clinicians at the bedside implement measure to attenuate the risk of unintended extubation in patients receiving neuromuscular-blocking agents. 5) Optimal clinical practice suggests that a reduced dose of an neuromuscular-blocking agent be used for patients with myasthenia gravis and that the dose should be based on peripheral nerve stimulation with train-of-four monitoring. 6) Optimal clinical practice suggests that neuromuscular-blocking agents be discontinued prior to the clinical determination of brain death.

17 Guideline Preventing Obesity and Eating Disorders in Adolescents. 2016

Golden, Neville H / Schneider, Marcie / Wood, Christine / Anonymous401238 / Anonymous411238 / Anonymous421238. · ·Pediatrics · Pubmed #27550979.

ABSTRACT: Obesity and eating disorders (EDs) are both prevalent in adolescents. There are concerns that obesity prevention efforts may lead to the development of an ED. Most adolescents who develop an ED did not have obesity previously, but some teenagers, in an attempt to lose weight, may develop an ED. This clinical report addresses the interaction between obesity prevention and EDs in teenagers, provides the pediatrician with evidence-informed tools to identify behaviors that predispose to both obesity and EDs, and provides guidance about obesity and ED prevention messages. The focus should be on a healthy lifestyle rather than on weight. Evidence suggests that obesity prevention and treatment, if conducted correctly, do not predispose to EDs.

18 Guideline AAP Updates Recommendations for Routine Preventive Pediatric Health Care. 2016

Lambert, Mara. · ·Am Fam Physician · Pubmed #27548604.

ABSTRACT: Run by Jan 2017.

19 Guideline Practice Policy Statement: Integrating Effective Weight Management Into Practice. 2016

Edshteyn, Ingrid / Uduhiri, Kelechi A / Morgan, Toyosi O / Rhodes, Katrina L / Sherin, Kevin M / Anonymous181260. ·Yale-Griffin Prevention Research Center, Derby, Connecticut. Electronic address: iedshteyn@gmail.com. · Providence Hospital, Washington, District of Columbia. · Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, Georgia. · American Association of Public Health Physicians, Green Cove Springs, Florida. · Department of Family Medicine, Florida State University College of Medicine, Tallahassee, Florida; University of Central Florida College of Medicine, Orlando, Florida; Florida Department of Health in Orange County, Orlando, Florida. ·Am J Prev Med · Pubmed #27374207.

ABSTRACT: The American College of Preventive Medicine Prevention Practice Committee contributes to policy guidelines and recommendations on preventive health topics for clinicians and public health decision makers. As an update to a previously published statement on weight management counseling of overweight adults, the College is providing a consensus-based recommendation designed to more effectively integrate weight management strategies into clinical practice and to incorporate referrals to effective evidence-based community and commercial weight management programs. The goal is to empower providers to include lifestyle interventions as part of the foundation of clinical practice.

20 Guideline Surgical Management of Osteoarthritis of the Knee: Evidence-based Guideline. 2016

McGrory, Brian J / Weber, Kristy L / Jevsevar, David S / Sevarino, Kaitlyn. ·From the Division of Joint Replacement, the Department of Orthopedics and Sports Medicine, Maine Medical Partners, Falmouth, ME (Dr. McGrory), the Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA (Dr. Weber), the Department of Orthopaedics and Sports Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH (Dr. Jevsevar), and the American Academy of Orthopaedic Surgeons (Ms. Sevarino). ·J Am Acad Orthop Surg · Pubmed #27355286.

ABSTRACT: Surgical Management of Osteoarthritis of the Knee: Evidence-based Guideline is based on a systematic review of the current scientific and clinical research. The guideline contains 38 recommendations pertaining to the preoperative, perioperative, and postoperative care of patients with osteoarthritis (OA) of the knee who are considering surgical treatment. The purpose of this clinical practice guideline is to help improve surgical management of patients with OA of the knee based on current best evidence. In addition to guideline recommendations, the work group highlighted the need for better research on the surgical management of OA of the knee.

21 Guideline Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. 2016

Martin, K / Beyer-Westendorf, J / Davidson, B L / Huisman, M V / Sandset, P M / Moll, S. ·Department of Medicine, Division of Hematology-Oncology, University of North Carolina, Chapel Hill, NC, USA. · Thrombosis Research Unit, Center for Vascular Diseases, University Hospital, Technische Universität Dresden, Dresden, Germany. · Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, Seattle, WA, USA. · Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands. · Department of Hematology, Oslo University Hospital and University of Oslo, Oslo, Norway. ·J Thromb Haemost · Pubmed #27299806.

ABSTRACT: -- No abstract --

22 Guideline 8 USPSTF recommendations FPs need to know about. 2016

Campos-Outcalt, Doug. ·Medical Director, Mercy Care Plan, Phoenix, AZ, USA. Email: campos-outcaltd@mercycareplan.com. ·J Fam Pract · Pubmed #27275937.

ABSTRACT: Treat high blood pressure only if measurements taken outside of the office confirm an initial high BP reading · Screen blood-glucose levels in overweight/obese individuals 40 to 70 years old · and more.

23 Guideline 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. 2016

Ponikowski, Piotr / Voors, Adriaan A / Anker, Stefan D / Bueno, Héctor / Cleland, John G F / Coats, Andrew J S / Falk, Volkmar / González-Juanatey, José Ramón / Harjola, Veli-Pekka / Jankowska, Ewa A / Jessup, Mariell / Linde, Cecilia / Nihoyannopoulos, Petros / Parissis, John T / Pieske, Burkert / Riley, Jillian P / Rosano, Giuseppe M C / Ruilope, Luis M / Ruschitzka, Frank / Rutten, Frans H / van der Meer, Peter / Anonymous451311. · ·Eur Heart J · Pubmed #27206819.

ABSTRACT: -- No abstract --

24 Guideline BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. 2016

Cooper, Stephen J / Reynolds, Gavin P / Anonymous370992 / Barnes, Tre / England, E / Haddad, P M / Heald, A / Holt, Rig / Lingford-Hughes, A / Osborn, D / McGowan, O / Patel, M X / Paton, C / Reid, P / Shiers, D / Smith, J. ·Professor of Psychiatry (Emeritus), Queen's University Belfast, UK Clinical Lead for the National Audit of Schizophrenia, Centre for Quality Improvement, Royal College of Psychiatrists, London, UK sjcooperqub@gmail.com. · Professor (Emeritus), Queen's University Belfast, UK Honorary Professor of Neuroscience, Sheffield Hallam University, Sheffield, UK. · Professor of Psychiatry, The Centre for Mental Health, Imperial College London, London, UK. · General Practitioner, Laurie Pike Health Centre, Birmingham, UK. · Honorary Clinical Professor of Psychiatry, University of Manchester, Manchester, UK Consultant Psychiatrist, Greater Manchester West Mental Health NHS Foundation Trust, Salford, UK. · Consultant Physician, Leighton and Macclesfield Hospitals, Cheshire, UK Research Fellow, University of Manchester, Manchester, UK. · Professor in Diabetes and Endocrinology, Human Development and Health Academic Unit, University of Southampton, Southampton, UK. · Professor of Addiction Biology, Imperial College, London, UK Consultant Psychiatrist, CNWL NHS Foundation Trust, London, UK. · Professor of Psychiatric Epidemiology and Honorary Consultant Psychiatrist, Division of Psychiatry UCL, London, UK. · Trainee in Psychiatry, Hairmyres Hospital, Glasgow, UK. · Honorary Senior Lecturer, King's College London, IOPPN, Department of Psychosis Studies PO68, London, UK. · Chief Pharmacist, Oxleas NHS Foundation Trust, Dartford, UK Joint-Head, Prescribing Observatory for Mental Health, CCQI, Royal College of Psychiatrists, London, UK. · Policy Manager, Rethink Mental Illness, London, UK. · Primary Care Lead for the National Audit of Schizophrenia, Centre for Quality Improvement, Royal College of Psychiatrists, London, UK. · Professor of Early Intervention and Psychosis, University of Worcester, Worcester, UK. ·J Psychopharmacol · Pubmed #27147592.

ABSTRACT: Excess deaths from cardiovascular disease are a major contributor to the significant reduction in life expectancy experienced by people with schizophrenia. Important risk factors in this are smoking, alcohol misuse, excessive weight gain and diabetes. Weight gain also reinforces service users' negative views of themselves and is a factor in poor adherence with treatment. Monitoring of relevant physical health risk factors is frequently inadequate, as is provision of interventions to modify these. These guidelines review issues surrounding monitoring of physical health risk factors and make recommendations about an appropriate approach. Overweight and obesity, partly driven by antipsychotic drug treatment, are important factors contributing to the development of diabetes and cardiovascular disease in people with schizophrenia. There have been clinical trials of many interventions for people experiencing weight gain when taking antipsychotic medications but there is a lack of clear consensus regarding which may be appropriate in usual clinical practice. These guidelines review these trials and make recommendations regarding appropriate interventions. Interventions for smoking and alcohol misuse are reviewed, but more briefly as these are similar to those recommended for the general population. The management of impaired fasting glycaemia and impaired glucose tolerance ('pre-diabetes'), diabetes and other cardiovascular risks, such as dyslipidaemia, are also reviewed with respect to other currently available guidelines.These guidelines were compiled following a consensus meeting of experts involved in various aspects of these problems. They reviewed key areas of evidence and their clinical implications. Wider issues relating to primary care/secondary care interfaces are discussed but cannot be resolved within guidelines such as these.

25 Guideline SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). 2016

Santini, Ferruccio / Busetto, Luca / Cresci, Barbara / Sbraccia, Paolo. ·Obesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy. · Department of Medicine, University of Padua, Padua, Italy. · Section of Diabetology, Careggi University Hospital, Florence, Italy. · Department of Systems Medicine, Medical School, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy. sbraccia@med.uniroma2.it. ·Eat Weight Disord · Pubmed #27100225.

ABSTRACT: -- No abstract --

Next